NCT01149174View on ClinicalTrials.gov

Preoperative Intravesical Electromotive Mitomycin-c for Primary Non-muscle Invasive Bladder Cancer

PHASE3CompletedINTERVENTIONAL

Enrollment

352

Participants

Timeline

Start Date

January 31, 1994

Primary Completion Date

December 31, 2003

Study Completion Date

June 30, 2009

Conditions

Superficial Bladder Cancer

Interventions

DRUG

Mitomycin-C 40 mg

Intravesical instillation of Mitomycin-C

Trial Locations (1)

00133

Dept. of Surgery, Tor Vergata University, Rome

All Listed Sponsors

lead

University of Rome Tor Vergata

OTHER